NN 623

structure in first source

Also Known As:

NN-623; NN623

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Type 2 Diabetes Mellitus (MODY) 09/01/1996 - "Both fasting and postprandial hyperglycaemia were reduced after 1 to 4 weeks of premeal treatment with 0.5 mg NN623 or 60 mg A4166 in subjects with NIDDM. " 09/01/1996 - "Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycaemic agents, NN623 and A4166."

1.	Nateglinide (Starlix)